Reck, M., Ferentinos, K., Joerger, M., Cobo, M., Thiele, B., D'Arcangelo, M., Sanmamed, M. F., Alexander, M., Desai, A., Gray, J. E., Herbst, R. S., Nieva, J. J., Veluswamy, R., Klar, K., Fox, M., Radulovic, V., Lemke, L., Leo, E., Rao, S., Lichtenegger, F. S. (2026). Phase 2b randomized, blinded, placebo-controlled trial to investigate the efficacy and safety of visugromab added to pembrolizumab, pemetrexed, and carboplatin in first-line metastatic non-squamous NSCLC: GDFATHER-NSCLC-01.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8665